𝔖 Bobbio Scriptorium

✦ LIBER ✦

The human Y chromosome suppresses the tumorigenicity of PC-3, a human prostate cancer cell line, in athymic nude mice

✍ Scribed by Sapna Vijayakumar; Dawn Garcia; Chuck H. Hensel; Mohua Banerjee; Todd Bracht; RuiHua Xiang; Jacob Kagan; Susan L. Naylor

Publisher: John Wiley and Sons
Year: 2005
Tongue: English
Weight: 433 KB
Volume: 44
Category: Article
ISSN: 1045-2257
DOI: 10.1002/gcc.20250

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

The loss of the Y chromosome is a frequent numerical chromosomal abnormality observed in human prostate cancer. In cancer, loss of specific genetic material frequently accompanies simultaneous inactivation of tumor suppressor genes. It is not known whether the Y chromosome harbors such genes. To address the role of genes on the Y chromosome in human prostate cancer, we transferred a tagged Y chromosome into PC‐3, a human prostate cancer cell line lacking a Y chromosome. A human Y chromosome was tagged with the hisD gene and transferred to PC‐3 by microcell‐mediated chromosome transfer. Tumorigenicity of these PC‐3 hybrids was tested in vivo and in vitro, and the results were compared with those of the polymerase chain reaction analyses conducted on the PC‐3 hybrids using Y chromosome‐specific markers. Among 60 mice injected with 12 different PC‐3 hybrids (five mice per hybrid), tumor growth was apparent in only one mouse, whereas tumors grew in all mice injected with the parental PC‐3 cells. An in vitro assay showed that the Y chromosome did not suppress anchorage‐independent growth of PC‐3 cells. We found that addition of the Y chromosome suppressed tumor formation by PC‐3 in athymic nude mice, and that this block of tumorigenesis was independent of the in vitro growth properties of the cells. This observation suggests the presence of a gene important for prostate tumorigenesis on the Y chromosome. © 2005 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Suppression of tumorigenicity in the hum

Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19

✍ Caroline Astbury; Colleen K. Jackson-Cook; Stephen H. Culp; Thomas E. Paisley; J 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 1 views

## Abstract Previously we immortalized human, nontransformed prostate epithelial cells with SV40 large T‐antigen (SV40TAg) and derived increasingly aggressive sublines from the immortalized line. The progression of the tumorigenic sublines to metastatic capacity was accompanied by the formation of

The norepinephrine-driven metastasis dev

The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers

✍ Daniel Palm; Kerstin Lang; Bernd Niggemann; Theodore L. Drell IV; Kai Masur; Kur 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 267 KB 👁 1 views

## Abstract The development of metastases is a decisive step in the course of a cancer disease. The detection of metastases in cancer patients is correlated with a poor prognosis, and over 90% of all deaths from cancer are not due to the primary tumor, which often can be successfully treated, but a

Genistein, a soy isoflavone, induces glu

Genistein, a soy isoflavone, induces glutathione peroxidase in the human prostate cancer cell lines LNCaP and PC-3

✍ Kazuhiro Suzuki; Hidekazu Koike; Hiroshi Matsui; Yoshihiro Ono; Masaru Hasumi; H 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 174 KB 👁 1 views

## Abstract Genistein is a major component of soybean isoflavone and has multiple functions resulting in antitumor effects. Prostate cancer is 1 of the targets for the preventive role of genistein. We examined the effect of genistein on human prostate cancer (LNCaP and PC‐3) cells. Proliferation of

Inhibition of osteoblastic cell differen

Inhibition of osteoblastic cell differentiation by conditioned medium derived from the human prostatic cancer cell line PC-3 in vitro

✍ Jun-ichi Kido; Noriyuki Yamauchi; Keiji Ohishi; Masatoshi Kataoka; Seiji Nishika 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

Human prostatic carcinoma frequently metastasizes to bone tissue and activates bone metabolism, especially bone formation, at the site of metastasis. It has been reported that an extract of prostatic carcinoma and conditioned medium (CM) of a human prostatic carcinoma cell line, PC-3, established fr

Effect of dibutyryl cyclic AMP on the ce

Effect of dibutyryl cyclic AMP on the cell cycle of human pancreatic cancer inoculated in nude mice

✍ A. Umezawa; K. Koyama; J. Tanaka; Y. Sato; Y. Asanuma 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 408 KB

## Abstract The prognosis of pancreatic cancer is very poor because of its high malignant potential. To improve the prognosis of pancreatic cancer, a decrease in the grade of maligancy by dibutyryl cyclic AMP (db‐cAMP), a differentiation inducer, was attempted using human pancreatic cancer cell lin

Growth-inhibitory effects of luteinizing

Growth-inhibitory effects of luteinizing hormone-releasing hormone (LHRH) agonists on xenografts of the DU 145 human androgen-independent prostate cancer cell line in nude mice

✍ Donatella Dondi; Roberta M. Moretti; Marina Montagnani Marelli; Graziella Prates 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 131 KB 👁 2 views

Experiments have been performed to clarify whether LHRH agonists might decrease growth of hormone-unresponsive prostate cancer in vivo. Male nude mice were injected s.c. with the human androgen-independent prostate tumor DU 145 cells; osmotic minipumps releasing the LHRH agonist Zoladex (LHRH-A) for